ヨーロッパの肺炎球菌ワクチン市場は2023年に約12億3,000万米ドルと評価され、2024年から2032年の予測期間にわたって5.84%を超える健全な成長率で成長すると予想されています。
肺炎球菌ワクチンは、肺炎球菌としても知られる肺炎連鎖球菌による感染を予防するワクチンです。この細菌は、肺炎、髄膜炎、菌血症を引き起こす可能性があります。ワクチン接種は、免疫系を刺激して特定の細菌株に対する抗体を生成し、感染を予防することによって機能します。また、ワクチン技術の継続的な進歩により、有効性と安全性プロファイルが向上した改良型肺炎球菌ワクチンが開発されました。これにより、医療提供者と患者がより新しく効果的なワクチンを選択するため、市場の成長がさらに刺激されました。したがって、この傾向は、ヨーロッパの肺炎球菌ワクチン市場の成長をサポートすると予想されます。
さらに、肺炎やその他の肺炎球菌性疾患の予防における肺炎球菌ワクチン接種の重要性についての医療従事者や一般大衆の認識が高まっていることも、ワクチンの需要を牽引しています。また、乳児、子供、高齢者の肺炎球菌性疾患の予防を目的とした政府の取り組みやワクチン接種プログラムも、市場の成長に大きく貢献しています。これらの取り組みには、無料または補助金付きのワクチン接種プログラムが含まれることが多く、アクセスしやすく手頃な価格になっています。さらに、特に乳児、高齢者、免疫力が弱い人などの脆弱な集団における肺炎、髄膜炎、敗血症などの肺炎球菌性疾患の発生率の増加も、肺炎球菌ワクチンの需要を後押ししています。ただし、厳格な規制プロセスと承認要件により、2024年から2032年の予測期間中、ヨーロッパの肺炎球菌ワクチン市場の成長が妨げられると予想されます。
ヨーロッパの肺炎球菌ワクチン市場調査の対象となる主要国には、イギリス、ドイツ、フランス、イタリア、スペイン、その他のヨーロッパ諸国が含まれます。2023年には、収益の面でドイツが最大の市場となりました。肺炎、髄膜炎、敗血症などの肺炎球菌性疾患の発生率の上昇により、肺炎球菌ワクチンの需要が高まっています。高齢者人口や肺炎球菌感染症にかかりやすい慢性疾患を持つ人が増えるにつれて、ワクチン接種などの予防策に関する意識が高まっています。一方、イギリスは2024年から2032年の予測期間中に最も高いCAGRで成長すると予想されています。
目次
Table of Contents
Chapter 1. Europe Pneumococcal Vaccine Market Definition and Research Assumptions
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates
Chapter 2. Executive Summary
2.1. Europe Pneumococcal Vaccine Market Size & Forecast (2022- 2032)
2.2. Regional Summary
2.3. Segmental Summary
2.3.1. By Vaccine Type
2.3.2. By Product
2.3.3. By End-use
2.4. Key Trends
2.5. Recession Impact
2.6. Analyst Recommendation & Conclusion
Chapter 3. Europe Pneumococcal Vaccine Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
Chapter 4. Europe Pneumococcal Vaccine Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Europe Pneumococcal Vaccine Market Size & Forecasts by Vaccine Type 2022-2032
5.1. Pneumococcal Conjugate Vaccine
5.2. Pneumococcal Polysaccharide Vaccine
Chapter 6. Europe Pneumococcal Vaccine Market Size & Forecasts by Product 2022-2032
6.1. Prevnar 13
6.2. Synflorix
6.3. Pneumovax 23
6.4. Vaxneuvance
6.5. Pneumosil
6.6. Other Products
Chapter 7. Europe Pneumococcal Vaccine Market Size & Forecasts by End-use 2022-2032
7.1. Public Sector
7.2. Private Sector
Chapter 8. Europe Pneumococcal Vaccine Market Size & Forecasts by Country 2022-2032
8.1. U.K. Pneumococcal Vaccine Market
8.1.1. Vaccine Type breakdown size & forecasts, 2022-2032
8.1.2. Product breakdown size & forecasts, 2022-2032
8.1.3. End-use breakdown size & forecasts, 2022-2032
8.2. Germany Pneumococcal Vaccine Market
8.3. France Pneumococcal Vaccine Market
8.4. Spain Pneumococcal Vaccine Market
8.5. Italy Pneumococcal Vaccine Market
8.6. Rest of Europe Pneumococcal Vaccine Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. GSK plc
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Sanofi SE
9.3.3. Company 3
9.3.4. Company 4
9.3.5. Company 5
9.3.6. Company 6
9.3.7. Company 7
9.3.8. Company 8
9.3.9. Company 9
9.3.10. Company 10
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
List of Tables
TABLE 1. Europe Pneumococcal Vaccine market, report scope
TABLE 2. Europe Pneumococcal Vaccine market estimates & forecasts by Country 2022-2032 (USD Billion)
TABLE 3. Europe Pneumococcal Vaccine market estimates & forecasts by Vaccine Type 2022-2032 (USD Billion)
TABLE 4. Europe Pneumococcal Vaccine market estimates & forecasts by Product 2022-2032 (USD Billion)
TABLE 5. Europe Pneumococcal Vaccine market estimates & forecasts by End-use 2022-2032 (USD Billion)
TABLE 6. Europe Pneumococcal Vaccine market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 7. Europe Pneumococcal Vaccine market by country, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 8. Europe Pneumococcal Vaccine market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 9. Europe Pneumococcal Vaccine market by country, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 10. Europe Pneumococcal Vaccine market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 11. Europe Pneumococcal Vaccine market by country, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 12. Europe Pneumococcal Vaccine market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 13. Europe Pneumococcal Vaccine market by country, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 14. Europe Pneumococcal Vaccine market by segment, estimates & forecasts, 2022-2032 (USD Billion) Europe Pneumococcal Vaccine market by country, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 15. UK Pneumococcal Vaccine market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 16. UK Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 17. UK Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 18. Germany Pneumococcal Vaccine market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 19. Germany Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 20. Germany Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 21. France Pneumococcal Vaccine market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 22. France Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 23. France Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 24. Italy Pneumococcal Vaccine market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 25. Italy Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 26. Italy Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 27. Spain Pneumococcal Vaccine market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 28. Spain Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 29. Spain Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 30. RoE Pneumococcal Vaccine market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 31. RoE Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 32. RoE Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 33. List of secondary sources, used in the study of Europe Pneumococcal Vaccine Market.
TABLE 34. List of primary sources, used in the study of Europe Pneumococcal Vaccine Market.
TABLE 35. Years considered for the study.
TABLE 36. Exchange rates considered
List of figures
FIG 1. Europe Pneumococcal Vaccine market, research methodology
FIG 2. Europe Pneumococcal Vaccine market, market estimation techniques
FIG 3. Europe market size estimates & forecast methods.
FIG 4. Europe Pneumococcal Vaccine market, key trends 2023
FIG 5. Europe Pneumococcal Vaccine market, growth prospects 2022-2032
FIG 6. Europe Pneumococcal Vaccine market, porters 5 force model
FIG 7. Europe Pneumococcal Vaccine market, pestel analysis
FIG 8. Europe Pneumococcal Vaccine market, value chain analysis
FIG 9. Europe Pneumococcal Vaccine market by segment, 2022 & 2032 (USD Billion)
FIG 10. Europe Pneumococcal Vaccine market by segment, 2022 & 2032 (USD Billion)
FIG 11. Europe Pneumococcal Vaccine market by segment, 2022 & 2032 (USD Billion)
FIG 12. Europe Pneumococcal Vaccine market by segment, 2022 & 2032 (USD Billion)
FIG 13. Europe Pneumococcal Vaccine market by segment, 2022 & 2032 (USD Billion)
FIG 14. Europe Pneumococcal Vaccine market, Country snapshot 2022 & 2032
FIG 15. Europe Pneumococcal Vaccine market 2022 & 2032 (USD Billion)
FIG 16. Europe Pneumococcal Vaccine market, company market share analysis (2023)
